The use of bone morphogenetic protein-6 gene therapy for percutaneous spinal fusion in rabbits

Journal of Neurosurgery

Volumn 101, Issue 1 SUPPL., 2004, Pages 90-94

  Laurent, Jeffrey J ^b   Webb, K Michael ^b   Beres, Elisa J ^b   McGee, Kevin ^b   Li, Jinzhong ^b   Van Rietbergen, Bert ^b   Helm, Gregory A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE

Author keywords

Adenovirus; Bone morphogenetic protein 6; Gene therapy; Spinal fusion

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BMP6 GENE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FLUOROSCOPY; GENE; GENE THERAPY; GRAFT SURVIVAL; HISTOPATHOLOGY; HISTORY OF MEDICINE; MICROSCOPIC ANATOMY; NONHUMAN; PATHOLOGICAL ANATOMY; PRIMATE; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDARTHROSIS; RABBIT; SPINE FUSION; TREATMENT INDICATION; VERTEBRA; VIRAL GENE DELIVERY SYSTEM; ANIMAL; GENETICS; LUMBAR VERTEBRA; PATHOLOGY; RADIOGRAPHY;

ADENOVIRIDAE; ANIMALS; BONE MORPHOGENETIC PROTEINS; GENE THERAPY; LUMBAR VERTEBRAE; MODELS, ANIMAL; RABBITS; SPINAL FUSION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3042597712     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/spi.2004.1.1.0090     Document Type: Article

References (39)

1. Alden TD, Beres EJ, Laurent JS, et al: The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J Craniofac Surg 11:24-30, 2000
2. Alden TD, Hankins GR, Beres EJ, et al: Bone morphogenetic protein gene therapy for the induction of spinal arthrodesis. Neurosurg Focus 4(2):Article 12, 1998
3. Alden TD, Pittman DD, Beres EJ, et al: Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg (Spine 1) 90:109-114, 1999
4. Alden TD, Pittman DD, Hankins GR, et al: In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther 10:2245-2253, 1999
5. Boden SD: Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation. Tissue Eng 6: 383-399, 2000
6. Boden SD, Moskovitz PA, Morone MA, et al: Video-assisted lateral intertransverse process arthrodesis. Validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models. Spine 21:2689-2697, 1996
7. Boden SD, Titus L, Hair G, et al: Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 23:2486-2492, 1998
8. Canalis E, McCarthy T, Centrella M: Growth factors and the regulation of bone remodeling. J Clin Invest 81:277-281, 1988
9. Cheng JC, Guo X, Law LP, et al: How does recombinant human bone morphogenetic protein-4 enhance posterior spinal fusion? Spine 27:467-474, 2002
10. Cheng SL, Lou J, Wright NM, et al: In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcif Tissue Int 68:87-94, 2001
11. Cook SD, Baffes GC, Wolfe MW, et al: The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 76:827-838, 1994
12. DePalma AF, Rothman RH: The nature of pseudoarthrosis. Clin Orthop 59:113-118, 1968
13. Dumont RJ, Dayoub H, Li JZ, et al: Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery 51: 1239-1245, 2002
14. Feiertag MA, Boden SD, Schimandle JH, et al: A rabbit model for nonunion of lumbar intertransverse process spine arthrodesis. Spine 21:27-31, 1996
15. Franceschi RT, Wang D, Krebsbach PH, et al: Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 78:476-486, 2000
16. Gazit D, Turgeman G, Kelley P, et al: Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy. J Gene Med 1: 121-133, 1999
17. Helm GA, Alden TD, Beres EJ, et al: Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg (Spine 2) 92:191-196, 2000
18. Helm GA, Alden TD, Sheehan JP, et al: Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: a review. Neurosurgery 46:1213-1222, 2000
19. Hibbs R: An operation for progressive spinal deformity. NY Med 121:1013, 1911
20. Jane JA Jr, Dunford BA, Kron A, et al: Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. Mol Ther 6:464-470, 2002
21. Lieberman JR, Daluiski A, Stevenson S, et al: The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 81: 905-917, 1999
22. Lieberman JR, Le LQ, Wu L, et al: Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 16:330-339, 1998
23. Morone MA, Boden SD, Hair G, et al: The Marshall R. Urist Young Investigator Award. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2. Clin Orthop 351:252-265, 1998
24. Moutsatsos IK, Turgeman G, Zhou S, et al: Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3:449-461, 2001
25. Musgrave DS, Bosch P, Ghivizzani S, et al: Adenovirus-mediated direct gene therapy with bone morphogenefic protein-2 produces bone. Bone 24:541-547, 1999
26. Pelled G, G T, Aslan H, et al: Mesenchymal stem cells for bone gene therapy and tissue engineering. Curr Pharm Des 8: 1917-1928, 2002
27. Riew KD, Wright NM, Cheng S, et al: Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int 63:357-360, 1998
28. Sandhu HS, Kanim LE, Kabo JM, et al: Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 21:2115-2122, 1996
29. Sandhu HS, Kanim LE, Toth JM, et al: Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine 22: 1171-1180, 1997. Erratum in Spine 15:2463, 1997
30. Sandhu HS, Kanim LE, Toth JM, et al: Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine 22: 1171-1180, 1997. Erratum in Spine 15:2463, 1997
31. Sandhu HS, Khan SN, Suh DY, et al: Demineralized bone matrix, bone morphogenetic proteins, and animal models of spine fusion: an overview. Eur Spine J 10:S122-S131, 2001
32. Schimandle JH, Boden SD, Hutton WC: Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 20:1326-1337, 1995
33. Sheehan JP, Kallmes DF, Sheehan JM, et al: Molecular methods of enhancing lumbar spine fusion. Neurosurgery 39: 548-554, 1996
34. Steinmann J, Herkowitz H: Pseudoarthrosis of the spine. Clin Orthop 284:80-90, 1992
35. Suh DY, Boden SD, Louis-Ugbo J, et al: Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine 27:353-360, 2002
36. Turgeman G, Aslan H, Gazit Z, et al: Cell-mediated gene therapy for bone formation and regeneration. Curr Opin Mol Ther 4:390-394, 2002
37. Turgeman G, Pittman DD, Muller R, et al: Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 3:240-251, 2001
38. Turgeman G, Zilberman Y, Zhou S, et al: Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J Cell Biochem 86:461-474, 2002
39. Varady P, Li JZ, Cunningham M, et al: Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum Gene Ther 12:697-710, 2001